1,665
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Commentary on guidelines for the pharmacological treatment of paraphilic disorders

References

  • Aggrawal A. 2009. References to the paraphilias and sexual crimes in the bible. J Forensic Legal Med. 16(3):109–114.
  • Briken P. 2020. A randomized clinical trial in patients with a pedophilic disorder. A milestone. JAMA Psychiatry. 77(9):893–894.
  • Briken P, Berner W, Group TPS. 2012. Double-blind, controlled, clinical trial planned in Germany to investigate the efficacy of psychotherapy combined with triptorelin in adult male patients with severe pedophilic disorders: presentation of the study protocol. Israel J Psychiatry Relat Sci. 49(4):306–313.
  • Bucklen KB. 2020. Conducting randomized controlled trials in state prisons. Washington (DC): U.S. Department of Justice, Office of Justice Programs, National Institute of Justice.
  • Darwin CR. 1862. On the two forms, or dimorphic condition, in the species of Primula, and on their remarkable sexual relations. J Proc Linn Soc Lond. 6(22):77–96.
  • Gallo A, Abracen J, Looman J, Jeglic E, Dickey R. 2019. The use of leuprolide acetate in the management of high-risk sex offenders. Sex Abuse. 31(8):930–951.
  • Konstenius M, Jayaram-Lindström N, Guterstam J, Beck O, Philips B, Franck J. 2014. Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction. 109(3):440–449.
  • Landgren V, Malki K, Bottai M, Arver S, Rahm C. 2020. Effect of gonadotropin-releasing hormone antagonist on risk of committing child sexual abuse in men with pedophilic disorder. A randomized clinical trial. JAMA Psychiatry. 77(9):897–899.
  • Langstrom N, Enebrink P, Lauren E-M, Lindblom J, Werko S, Hanson RK. 2013. Preventing sexual abusers of children from reoffending: Systematic review of medical and psychological interventions. BMJ. 347:f4630–17.
  • Letourneau, EJ, Brown, DS, Fang, X, Hassan, A, Mercy JA. 2018. The economic burden of child sexual abuse in the United States. Child Abuse Negl. 79:413–422.
  • Nelson RJ, Kriegsfeld LJ. 2017. An introduction to behavioral endocrinology. 5th ed. Sunderland (MA): Sinauer Associates, Inc.
  • Rosler A, Witztum E. 1998. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. New Eng J Med. 338(7):416–422.
  • Rosler A, Witztum E. 2009. One hundred men with severe paraphilia treated over a period of 15 years with a long-acting analogue of gonadotropin-releasing hormone: effects and side effects: Endocrine Society's 90th Annual Meeting.
  • Seto MC. 2018. Pedophilia and sexual offending against children: theory, assessment, and intervention. 2nd ed. Washington (DC): American Psychological Association.
  • Thibaut F, Bradford JMW, Briken P, De La Barra F, Häßler F, Cosyns P, WFSBP Task Force on Sexual Disorders. 2016. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders. World J Biol Psychiatry. 17(1):2–38.
  • Thibaut F, Cosyns P, Fedoroff JP, Briken P, Goethals K, Bradford JMW, The WFSBP Task Force on Paraphilias. 2020. The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders. World J Biol Psychiatry. 21:412–490. doi:10.1080/15622975.2020.1744723
  • Thibaut F, De La Barra F, Gordon H, Cosyns P, Bradford JMW, WFSBP Task Force on Sexual Disorders. 2010. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias. World J Biol Psychiatry. 11(4):604–655.
  • Wainberg ML, Muench F, Morgenstern J, Hollander E, Irwin TW, Parsons JT, Allen A, O'Leary A. 2006. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry. 67(12):1968–1973.
  • Yetisen AK, Martinez-Hurtado JL, Ünal B, Khademhosseini A, Butt H. 2018. Wearables in medicine. Adv Mater. 30:1–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.